Gerald R. Ewoldt

Array ( [id] => 1376676 [patent_doc_number] => 06551589 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Method of reducing the chance of attack of cells in a body by the cellular immune systems' [patent_app_type] => B1 [patent_app_number] => 09/561048 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6287 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/551/06551589.pdf [firstpage_image] =>[orig_patent_app_number] => 09561048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875074 [patent_doc_number] => 20020049302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Enriched antigen-specific-cells and related therapeutic and prophylactic compositions and methods' [patent_app_type] => new [patent_app_number] => 09/548648 [patent_app_country] => US [patent_app_date] => 2000-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4998 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049302.pdf [firstpage_image] =>[orig_patent_app_number] => 09548648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1357479 [patent_doc_number] => 06576745 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Human cystatin F antibodies' [patent_app_type] => B1 [patent_app_number] => 09/528436 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24410 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576745.pdf [firstpage_image] =>[orig_patent_app_number] => 09528436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778641 [patent_doc_number] => 20030049722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Novel methods of diagnosing macrophage developement related disorders, compositions, and methods of screening for macrophage developement modulators' [patent_app_type] => new [patent_app_number] => 09/525978 [patent_app_country] => US [patent_app_date] => 2000-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 27606 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049722.pdf [firstpage_image] =>[orig_patent_app_number] => 09525978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282488 [patent_doc_number] => 08216587 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-07-10 [patent_title] => 'Method of vaccination' [patent_app_type] => utility [patent_app_number] => 09/524454 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6256 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09524454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1126242 [patent_doc_number] => 06790662 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-14 [patent_title] => 'Method of isolating CD8 cells, and related hybridoma cells antibodies and polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/521527 [patent_app_country] => US [patent_app_date] => 2000-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2562 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790662.pdf [firstpage_image] =>[orig_patent_app_number] => 09521527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905047 [patent_doc_number] => 20020142000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Anti-CD3 immunotoxins and therapeutic uses therefor' [patent_app_type] => new [patent_app_number] => 09/480236 [patent_app_country] => US [patent_app_date] => 2000-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 23907 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142000.pdf [firstpage_image] =>[orig_patent_app_number] => 09480236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6462268 [patent_doc_number] => 20020150575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'METHOD TO SUPPRESS APPETITE AND REDUCE WEIGHT GAIN' [patent_app_type] => new [patent_app_number] => 09/479811 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3113 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150575.pdf [firstpage_image] =>[orig_patent_app_number] => 09479811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589824 [patent_doc_number] => 06482925 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants' [patent_app_type] => B1 [patent_app_number] => 09/319014 [patent_app_country] => US [patent_app_date] => 2000-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 9934 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482925.pdf [firstpage_image] =>[orig_patent_app_number] => 09319014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1314564 [patent_doc_number] => 06610833 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Monoclonal human natural antibodies' [patent_app_type] => B1 [patent_app_number] => 09/462118 [patent_app_country] => US [patent_app_date] => 1999-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 13306 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610833.pdf [firstpage_image] =>[orig_patent_app_number] => 09462118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4080047 [patent_doc_number] => 06162441 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Method for the production of anti-escherichia. coli O157 : H7 antibody' [patent_app_type] => 1 [patent_app_number] => 9/461919 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3122 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 299 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162441.pdf [firstpage_image] =>[orig_patent_app_number] => 461919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1290364 [patent_doc_number] => 06632928 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Immunotoxins and methods of inducing immune tolerance' [patent_app_type] => B1 [patent_app_number] => 09/380484 [patent_app_country] => US [patent_app_date] => 1999-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 24 [patent_no_of_words] => 28066 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632928.pdf [firstpage_image] =>[orig_patent_app_number] => 09380484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6375034 [patent_doc_number] => 20020119167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'HUMAN ADAMTS-1 PROTEIN, GENE CODING THE SAME, PHARMACEUTICAL COMPOSITION, AND METHOD FOR IMMUNOLOGICALLY ASSAYING HUMAN ADAMTS-1 PROTEIN' [patent_app_type] => new [patent_app_number] => 09/445023 [patent_app_country] => US [patent_app_date] => 1999-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14060 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119167.pdf [firstpage_image] =>[orig_patent_app_number] => 09445023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328911 [patent_doc_number] => 06329511 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Humanized antibodies to .gamma.-interferon' [patent_app_type] => 1 [patent_app_number] => 9/450520 [patent_app_country] => US [patent_app_date] => 1999-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 9907 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329511.pdf [firstpage_image] =>[orig_patent_app_number] => 450520 [rel_patent_id] =>[rel_patent_doc_number] =>)